You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

 

Online download statistics by month:

Online download statistics by month: May 2022 to March 2026

AbstractFullPdf
May 2022781799232
Jun 2022345350119
Jul 202226826876
Aug 202223223854
Sep 202221321975
Oct 202223023480
Nov 202223023369
Dec 202226927162
Jan 202322322472
Feb 2023270277119
Mar 202320020173
Apr 2023223229119
May 202323323899
Jun 202325325975
Jul 202320220355
Aug 202315215444
Sep 202318818970
Oct 202322823178
Nov 202322122667
Dec 202317617763
Jan 202411611848
Feb 202417817877
Mar 2024189191117
Apr 202418318594
May 202417517390
Jun 202413213269
Jul 2024273273111
Aug 202419619958
Sep 2024153155313
Oct 202417317499
Nov 202414814970
Dec 202415215380
Jan 202516816968
Feb 202527427797
Mar 202517117274
Apr 202521221273
May 2025198200103
Jun 202514715090
Jul 2025330
Sep 2025550
Jan 2026001
Mar 2026002
Total838384883435